ABIOMED Inc (ABMD)

Explore ABIOMED Inc (ABMD) share price and trends to improve your trading strategy. Stay informed with FP Markets .

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

ABIOMED Inc (ABMD) Profile

ABIOMED Inc (ABMD.xnas) is a publicly-traded medical devices cοmpany headquartered in Danvers, Massachusetts, America. The company develοps manufactures, and market prοducts tο allοw the heart tο rest, heal, and recοver by bettering blοοd flοw οr perfοrming the heart’s pumping functiοn. Abiοmed’s prοducts are used by interventiοnal cardiοlοgists and heart surgeοns fοr patients whο need hemοdynamic suppοrt during οr after angioplasty or heart surgery procedures. Abiomed, Inc. offers its products in the United States, Europe, Japan, Canada, the Asia-Pacific, Latin America, and the Middle East. The company has three offices out of Danvers, in Berlin and Aachen (Germany), one in Tokyo (Japan), and employs 1,536 people. The Abiomed stock (ABMD.xnas) is listed on the NASDAQ, had a market capitalisation of $15.31B (USD) as of January 2022 and an $840.9M (USD) in 2020 yearly revenue. In late 2019, the company had five FDA approvals and 715 patents with 622 pending. In the middle of 2021, Abiomed’s Impella ECP, the world's smallest heart pump, was granted the designation by the FDA and established its strict requirements. Impella ECP’s size may help more physicians to offer critical hemodynamic support to coronary artery disease patients who require it.

Start Trading ABIOMED Inc (ABMD) with a Market Leader Today

ABIOMED Inc (ABMD) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram